* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a rise in quarterly revenue when it reports results on
August 5.
* The Alhambra, California-based company is expected to report
a 3.5% increase in revenue to $170.9 million from $165.17
million a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical Holdings
Inc is for earnings of 21 cents per share. For the same quarter
last year, the company reported a loss of $1.75 per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Apollo Medical
Holdings Inc is $75, about 18.6% below its last closing price
of $88.92.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.22 0.22 0.30 Beat 36.4
Dec. 31 2020 0.18 0.18 0.27 Beat 50
Sep. 30 2020 0.22 0.22 0.45 Beat 104.5
Jun. 30 2020 0.07 0.07 -1.75 Missed -2,600
Mar. 0.04 0.04 0.11 Beat 175
31 2020
Dec. 31 2019 0.20 0.18 Missed -10
Sep. 30 2019 0.14 0.14 0.10 Missed -28.6
Jun. 30 2019 0.05 0.09 Beat 80
This summary was machine generated August 3 at 21:42 GMT. All
figures in US dollars unless otherwise stated